Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation

scientific article

Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10875-009-9293-9
P698PubMed publication ID19462221
P5875ResearchGate publication ID24446304

P2093author name stringXiao-Jun Huang
Ying-Jun Chang
Xiang-Yu Zhao
Ming-Rui Huo
P2860cites workOnly the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHDQ81014631
Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriersQ81676892
Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host diseaseQ82505877
Leukocyte migration and graft-versus-host diseaseQ30479618
Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsQ33594562
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysisQ34337007
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestineQ35848654
A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host diseaseQ36363382
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organsQ36478455
Selectins--potential pharmacological targets?Q36630618
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cellsQ36658080
Progress in acute graft versus host diseaseQ36953081
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challengesQ37023497
Late effects of chronic graft-versus-host diseaseQ37173489
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.Q37295704
The role of donor lymphoid cells in allogeneic marrow engraftmentQ38037580
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.Q40539710
Transfer of allogeneic CD62L- memory T cells without graft-versus-host diseaseQ40627364
Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cellsQ44006790
LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host diseaseQ44620762
Allogenic stem cell transplantation from genotypically HLA-identical siblings for 30 patients with myelodysplastic syndromesQ44923755
In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.Q45182123
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantationQ46870128
Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.Q47214419
Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at l-selectin and alpha4-integrin prior to infusionQ47614127
Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effectQ47989352
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.Q52006998
Lifespan of human lymphocyte subsets defined by CD45 isoformsQ52069544
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.Q53589050
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Q54684597
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor graftsQ56909451
Interleukin-11 induces Th2 polarization of human CD4(+) T cellsQ57007772
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationQ57252638
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.Q58416258
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsQ70051817
Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host diseaseQ71577663
Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host diseaseQ73444018
Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin- T cellsQ77304812
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportionsQ79854792
CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulinQ79901873
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesQ80045677
P433issue5
P304page(s)696-704
P577publication date2009-05-22
P1433published inJournal of Clinical ImmunologyQ6294961
P1476titleExpression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation
P478volume29

Reverse relations

cites work (P2860)
Q45165373A direct comparison of expression profiles of adhesion molecules on naïve T cells between cord blood and steady-state bone marrow grafts of healthy donors
Q38124285Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation
Q42235412Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.
Q58093525Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation
Q84255678High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation
Q45365962High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.
Q35155712Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro
Q50860969Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.
Q57216449Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease

Search more.